Annual COVID Booster Necessity

The strongest claim in the annual booster debate is that variant-targeted boosters reduce hospitalization risk by 50% in older adults, per CDC data, while natural immunity after infection offers durable protection for healthy adults under 40. The debate centers on whether annual doses are necessary for all, with Israel recommending them only for high-risk groups. Compared to #4’s annual COVID booster question, this issue is more scientifically fluid, evolving with each new variant. Concrete evidence: booster uptake dropped by 60% in 2023 versus 2022, yet a 2024 study found that vaccinated individuals had 70% lower mortality than those relying solely on prior infection.